ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.767,19
-1,73%
S&P 500
5.346,99
-0,11%
US Dollar vs BRL
5,3461
0,00%
Bitcoin
69.440,92
0,16%
Brent Oil
79,395
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. SurModics Inc (SRDX)

  7. SurModics Inc (SRDX) Notícias

SRDX

SurModics (SRDX)

SurModics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SRDX
DataHoraFonteTítuloCódigoCompanhia
29/05/202419:36PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc.NASDAQ:SRDXSurModics Inc
29/05/202409:04Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SRDXSurModics Inc
29/05/202408:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRDXSurModics Inc
29/05/202408:00Business WireSurmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 MillionNASDAQ:SRDXSurModics Inc
24/05/202417:01Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:SRDXSurModics Inc
01/05/202408:00Business WireSurmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial GuidanceNASDAQ:SRDXSurModics Inc
19/04/202408:00Business WireSurmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1NASDAQ:SRDXSurModics Inc
27/02/202410:00Business WireSurmodics to Participate in Upcoming Investor Conferences in March and AprilNASDAQ:SRDXSurModics Inc
12/02/202418:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRDXSurModics Inc
09/02/202413:20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SRDXSurModics Inc
01/02/202410:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SRDXSurModics Inc
01/02/202409:00Business WireSurmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial GuidanceNASDAQ:SRDXSurModics Inc
22/01/202409:30Business WireSurmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the KneeNASDAQ:SRDXSurModics Inc
16/01/202409:30Business WireSurmodics to Host Virtual Annual Meeting of ShareholdersNASDAQ:SRDXSurModics Inc
16/01/202409:30Business WireSurmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1NASDAQ:SRDXSurModics Inc
18/12/202318:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SRDXSurModics Inc
22/11/202312:22Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SRDXSurModics Inc
16/11/202309:30Business WireSurmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposiumNASDAQ:SRDXSurModics Inc
16/11/202309:30Business WireSurmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH SymposiumNASDAQ:SRDXSurModics Inc
14/11/202318:05Business WireSurmodics to Participate in the Piper Sandler Healthcare Conference on November 28NASDAQ:SRDXSurModics Inc
08/11/202309:30Business WireSurmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial GuidanceNASDAQ:SRDXSurModics Inc
07/11/202309:30Business WireSurmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH SymposiumNASDAQ:SRDXSurModics Inc
07/11/202309:30Business WireSurmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15NASDAQ:SRDXSurModics Inc
31/10/202308:30Business WireSurmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device ApplicationsNASDAQ:SRDXSurModics Inc
10/10/202308:30Business WireSurmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8NASDAQ:SRDXSurModics Inc
09/08/202318:05Business WireSurmodics to Participate in Upcoming Investor Conferences in AugustNASDAQ:SRDXSurModics Inc
02/08/202308:31Business WireSurmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial GuidanceNASDAQ:SRDXSurModics Inc
12/07/202308:30Business WireSurmodics to Report Third Quarter of Fiscal 2023 Financial Results on August 2NASDAQ:SRDXSurModics Inc
20/06/202312:10Dow Jones NewsSurmodics Shares Up 8% on FDA Approval for SurVeil Drug-Coated BalloonNASDAQ:SRDXSurModics Inc
20/06/202308:23Dow Jones NewsSurmodics Gets FDA Approval for SurVeil Drug-Coated BalloonNASDAQ:SRDXSurModics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SRDX

Seu Histórico Recente

DGFX
SOLIUSDT
Solana Ecosystem Index
NYSE
IDT.B
TSXV
CWN.P
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados